what has less side effects semaglutide or tirzepatide vs. for Weight Loss: Results, & How to Choose Tirzepatide vs. Semaglutide: Which is

Plasma Trimethylamine-N-oxide following Cessation of L-carnitine Supplementation in Healthy Aged Women

This study was conducted after approval by the Research Ethical Committee of Faculty of Medicine, Ain Shams University with approval number (FMASU M S 630/2022) in 22/6/2022

GLP-1 medications can rarely cause ileus (paralyzed bowel)

contamination or mis-labeled content is a real-world risk that no dosing table can protect against

We identified P5 in a high-throughput autocrine-based screening of large combinatorial peptide libraries, and show that P5 promotes G-protein signalling comparable to GLP-1 and Exendin-4, but exhibited a significantly reduced -arrestin response

Novo Nordisk submitted CagriSema for FDA approval, with a decision expected in late 2026